Source: GWASCAT
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
signal transducer and activator of transcription 4 | 0.471 | 0.769 | 0.77 |
|
disease | 0.700 | None | 0.961 | 16 | 10 | 2002 | 2020 | ||||||||
|
integrin subunit alpha M | 0.443 | 0.808 | 3.3E-11 |
|
disease | 0.700 | None | 1.000 | 9 | 6 | 2008 | 2019 | ||||||||
|
WDFY family member 4 | 0.792 | 0.192 | 0.34 |
|
disease | 0.140 | None | 1.000 | 8 | 7 | 2009 | 2018 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.700 | None | 0.926 | 8 | 5 | 2009 | 2019 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.390 | None | 0.944 | 8 | 6 | 2008 | 2019 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.700 | None | 0.929 | 7 | 4 | 2008 | 2019 | ||||||||
|
neutrophil cytosolic factor 2 | 0.601 | 0.692 | 4.0E-07 |
|
disease | 0.170 | None | 1.000 | 6 | 4 | 2009 | 2019 | ||||||||
|
SMG7 nonsense mediated mRNA decay factor | 0.805 | 0.346 | 1.00 |
|
disease | 0.110 | None | 1.000 | 6 | 4 | 2009 | 2019 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.800 | None | 0.952 | 6 | 1 | 2004 | 2019 | ||||||||
|
transportin 3 | 0.663 | 0.577 | 1.8E-06 |
|
disease | 0.130 | None | 1.000 | 6 | 6 | 2008 | 2020 | ||||||||
|
ubiquitin conjugating enzyme E2 L3 | 0.644 | 0.615 | 0.84 |
|
disease | 0.490 | None | 0.941 | 5 | 4 | 2008 | 2020 | ||||||||
|
UHRF1 binding protein 1 | 0.769 | 0.269 | 4.5E-13 |
|
disease | 0.430 | None | 0.857 | 5 | 5 | 2009 | 2019 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.130 | None | 1.000 | 5 | 4 | 2008 | 2019 | ||||||||
|
interferon regulatory factor 5 | 0.489 | 0.731 | 9.0E-03 |
|
disease | 0.700 | None | 0.949 | 5 | 5 | 2005 | 2020 | ||||||||
|
C-type lectin domain containing 16A | 0.612 | 0.654 | 0.28 |
|
disease | 0.410 | None | 1.000 | 4 | 5 | 2009 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.500 | None | 0.931 | 4 | 2 | 1991 | 2016 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.200 | None | 0.955 | 4 | 5 | 2005 | 2019 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
disease | 0.700 | None | 0.976 | 4 | 3 | 2008 | 2020 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
disease | 0.630 | None | 0.800 | 4 | 5 | 2009 | 2017 | ||||||||
|
solute carrier family 15 member 4 | 0.805 | 0.269 | 1.9E-06 |
|
disease | 0.440 | None | 1.000 | 4 | 4 | 2009 | 2017 | ||||||||
|
interleukin 12 receptor subunit beta 2 | 0.608 | 0.692 | 1.6E-09 |
|
disease | 0.110 | None | 1.000 | 4 | 4 | 2009 | 2019 | ||||||||
|
RAS guanyl releasing protein 3 | 0.686 | 0.500 | 9.1E-03 |
|
disease | 0.410 | None | 1.000 | 3 | 1 | 2009 | 2017 | ||||||||
|
Fc fragment of IgG receptor IIa | 0.480 | 0.769 | 2.0E-06 |
|
disease | 0.500 | None | 0.906 | 3 | 3 | 1995 | 2019 | ||||||||
|
AT-rich interaction domain 5B | 0.638 | 0.500 | 1.00 |
|
disease | 0.130 | None | 1.000 | 3 | 1 | 2012 | 2016 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2016 |